Get the Stockscreener App
161.25
1.26%
-2.06
After Hours:
161.25
Charles River Laboratories International Inc stock is traded at $161.25, with a volume of 528.96K.
It is down -1.26% in the last 24 hours and down -3.39% over the past month.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
See More
Previous Close:
$163.31
Open:
$160.95
24h Volume:
528.96K
Relative Volume:
0.62
Market Cap:
$7.94B
Revenue:
$4.06B
Net Income/Loss:
$413.08M
P/E Ratio:
20.13
EPS:
8.01
Net Cash Flow:
$560.48M
1W Performance:
-1.50%
1M Performance:
-3.39%
6M Performance:
-2.46%
1Y Performance:
-18.46%
1-Day Range:
$158.69
$162.44
1-Week Range:
$158.69
$165.22
52-Week Range:
$91.86
$230.02
Charles River Laboratories International Inc Stock (CRL) Company Profile
Name
Charles River Laboratories International Inc
Sector
Industry
Phone
781-222-6000
Address
251 BALLARDVALE ST, WILMINGTON, MA
Compare CRL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRL
Charles River Laboratories International Inc
|
161.25 | 8.04B | 4.06B | 413.08M | 560.48M | 8.01 |
|
TMO
Thermo Fisher Scientific Inc
|
487.53 | 186.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.79 | 147.38B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.45 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.21 | 35.62B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
183.74 | 32.44B | 15.70B | 1.24B | 2.01B | 6.91 |
Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Upgrade | Citigroup | Neutral → Buy |
| May-23-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| May-14-25 | Upgrade | TD Cowen | Hold → Buy |
| May-08-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-21-25 | Downgrade | Goldman | Buy → Neutral |
| Mar-04-25 | Upgrade | Citigroup | Sell → Neutral |
| Mar-03-25 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Jan-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-17-25 | Downgrade | UBS | Buy → Neutral |
| Nov-18-24 | Downgrade | CLSA | Hold → Underperform |
| Nov-07-24 | Upgrade | CLSA | Underperform → Hold |
| Oct-23-24 | Initiated | CLSA | Underperform |
| Oct-14-24 | Initiated | Redburn Atlantic | Sell |
| Oct-07-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-01-24 | Downgrade | Citigroup | Neutral → Sell |
| Aug-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-08-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-28-24 | Downgrade | Argus | Buy → Hold |
| Jun-07-24 | Initiated | Mizuho | Neutral |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-13-23 | Initiated | TD Cowen | Market Perform |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-23 | Upgrade | Guggenheim | Neutral → Buy |
| Jan-12-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-04-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-24-22 | Initiated | Guggenheim | Neutral |
| Apr-25-22 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-22 | Initiated | Stephens | Overweight |
| Feb-17-22 | Reiterated | BofA Securities | Buy |
| Feb-17-22 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-22 | Reiterated | Deutsche Bank | Buy |
| Feb-17-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-17-22 | Reiterated | UBS | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-20 | Upgrade | Jefferies | Hold → Buy |
| Jul-01-20 | Upgrade | BofA Securities | Neutral → Buy |
| May-13-20 | Upgrade | UBS | Neutral → Buy |
| Apr-21-20 | Downgrade | Jefferies | Buy → Hold |
| Mar-27-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Feb-18-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-10-20 | Upgrade | Goldman | Neutral → Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-18-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-10-19 | Initiated | SVB Leerink | Outperform |
| Apr-30-19 | Resumed | Evercore ISI | Outperform |
| Dec-14-18 | Initiated | Deutsche Bank | Buy |
| Oct-09-18 | Initiated | UBS | Neutral |
| Aug-23-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-17-18 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-15-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Feb-14-18 | Upgrade | SunTrust | Hold → Buy |
View All
Charles River Laboratories International Inc Stock (CRL) Latest News
Applying Wyckoff theory to Charles River Laboratories International Inc. stockJuly 2025 Selloffs & Safe Capital Growth Tips - Newser
Published on: 2025-09-02 14:56:06 - Newser
Developing predictive dashboards with Charles River Laboratories International Inc. dataEarnings Overview Report & Free Technical Pattern Based Buy Signals - Newser
Leading vs lagging indicators on Charles River Laboratories International Inc. performanceJuly 2025 Spike Watch & Stepwise Trade Signal Implementation - Newser
Using AI based signals to follow Charles River Laboratories International Inc.Wall Street Watch & Long-Term Investment Growth Plans - Newser
Will Charles River Laboratories International Inc. benefit from geopolitical trendsWeekly Earnings Recap & Reliable Momentum Entry Alerts - خودرو بانک
Price momentum metrics for Charles River Laboratories International Inc. explainedTrade Ideas & Fast Moving Stock Watchlists - Newser
Does Charles River Laboratories International Inc. stock have upside surprise potentialWeekly Profit Summary & Weekly Return Optimization Plans - خودرو بانک
Is Charles River Laboratories International Inc. forming a breakout patternJuly 2025 Volume & Community Consensus Trade Signals - خودرو بانک
Can a trend reversal in Charles River Laboratories International Inc. lead to recoveryMarket Movement Recap & Fast Entry Momentum Alerts - Newser
How sentiment analysis helps forecast Charles River Laboratories International Inc. - Newser
Is Charles River Laboratories International Inc. stock bottoming outQuarterly Market Review & Community Consensus Trade Signals - Newser
Advanced analytics toolkit walkthrough for Charles River Laboratories International Inc.Earnings Growth Report & Risk Adjusted Buy/Sell Alerts - Newser
Tools to assess Charles River Laboratories International Inc.’s risk profileMarket Trend Report & Growth Oriented Trading Recommendations - Newser
Real time scanner hits for Charles River Laboratories International Inc. explainedDividend Hike & Safe Capital Growth Tips - Newser
Charles River Laboratories International Inc. stock volume spike explainedTrade Entry Summary & Real-Time Buy Zone Alerts - Newser
Regression analysis insights on Charles River Laboratories International Inc. performanceEarnings Recap Summary & Safe Investment Capital Preservation Plans - Newser
Institutional scanner results for Charles River Laboratories International Inc.July 2025 Levels & Precise Buy Zone Identification - Newser
What earnings revisions data tells us about BigBear.ai Holdings Inc. Equity WarrantTrade Entry Summary & High Conviction Buy Zone Picks - Newser
How to use a screener to detect Charles River Laboratories International Inc. breakoutsJuly 2025 News Drivers & Fast Entry Momentum Alerts - Newser
How to track smart money flows in Charles River Laboratories International Inc.Trade Signal Summary & Expert Approved Momentum Ideas - Newser
What is Charles River Laboratories International Inc. s 5 year growth outlookRate Hike & Daily Market Momentum Tracking - خودرو بانک
Technical analysis overview for Charles River Laboratories International Inc. stock - Newser
Risk vs reward if holding onto Charles River Laboratories International Inc.Price Action & Reliable Entry Point Trade Alerts - Newser
Is Charles River Laboratories International Inc. meeting your algorithmic filter criteria2025 Trading Volume Trends & Expert Curated Trade Setup Alerts - Newser
Charles River Stock May Benefit From Joining EASYGEN Consortium - sharewise.com
Using data filters to optimize entry into Charles River Laboratories International Inc.2025 Analyst Calls & Growth Focused Entry Reports - Newser
How high can Charles River Laboratories International Inc. stock goWeekly Stock Analysis & AI Based Trade Execution Alerts - Newser
Recap Report: Is Charles River Laboratories International Inc. likely to announce a buybackJuly 2025 Recap & Accurate Technical Buy Alerts - خودرو بانک
Published on: 2025-09-01 11:07:51 - Newser
Short interest data insights for Banco Santander S.A. Depositary ReceiptMarket Sentiment Review & Comprehensive Market Scan Reports - Newser
Stock Analysis | Charles River Laboratories International OutlookMixed Signals Amid Earnings Optimism - AInvest
Published on: 2025-08-31 21:05:47 - Newser
Visualizing Charles River Laboratories International Inc. stock with heatmapsQuarterly Portfolio Summary & AI Powered Market Entry Ideas - Newser
Charles River Laboratories International Inc. stock trendline breakdownMarket Sentiment Summary & Proven Capital Preservation Methods - Newser
Charles River Laboratories International Inc. Reversal Rally May Surprise Bears2025 Fundamental Recap & Fast Exit/Entry Strategy Plans - beatles.ru
Analyzing Charles River Laboratories International Inc. with risk reward ratio charts2025 Retail Activity & Real-Time Volume Analysis - Newser
Building trade automation scripts for Charles River Laboratories International Inc.Buy Signal & Weekly Breakout Opportunity Watchlist - Newser
Has Charles River Laboratories International Inc. found a price floorPortfolio Return Report & Entry and Exit Point Strategies - Newser
What high frequency data says about Charles River Laboratories International Inc.Quarterly Trade Summary & Daily Technical Stock Forecast Reports - Newser
Will Charles River Laboratories International Inc. stock go up soonTrade Performance Summary & Low Risk Investment Opportunities - Newser
Combining price and volume data for Charles River Laboratories International Inc.July 2025 Action & Target Return Focused Picks - Newser
Published on: 2025-08-31 12:25:58 - Newser
Is it time to cut losses on Charles River Laboratories International Inc.2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - Newser
Is Charles River Laboratories International Inc. forming a bottoming baseJuly 2025 Final Week & Free Community Consensus Stock Picks - Newser
Charles River Laboratories International Inc Stock (CRL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.76%
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):